RxDoctor Payments Data

David Mull, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Shreveport, LANPI 1104974641

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Atricure, Inc. at 29.3% of the total. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in LA, where the typical reported total is $4,896.

$2,498in general payments, 2019–2025

Across 91 payments — averaging $27.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$733
  • Edwards Lifesciences$649
  • Abiomed$380
  • Boston Scientific$251
  • Baxter Healthcare$130
  • Johnson & Johnson$127
  • plus $228 from 5 others

What the payments were for

  • Food & beverage$2,498100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.40$733
Edwards Lifesciences19$649
Abiomed15$380
Boston Scientific3$251
Baxter Healthcare4$130
Johnson & Johnson(2 entities)5$127
Silk Road Medical, Inc.1$125
Intuitive Surgical1$51
Midsouth Orthopedics Inc.1$22
Lemaitre Vascular, Inc.1$17
On Target Laboratories, Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,498 in reported general payments places this provider in the 30th percentile of 75 thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Louisiana

Medicare billing

Part B allowed, 2024
$73,040
Medicare patients
64
Services billed
156

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$80

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →